234 related articles for article (PubMed ID: 28004802)
1. Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy.
Griffiths KL; Ahmed M; Das S; Gopal R; Horne W; Connell TD; Moynihan KD; Kolls JK; Irvine DJ; Artyomov MN; Rangel-Moreno J; Khader SA
Nat Commun; 2016 Dec; 7():13894. PubMed ID: 28004802
[TBL] [Abstract][Full Text] [Related]
2. Role of B Cells in Mucosal Vaccine-Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis.
Khera AK; Afkhami S; Lai R; Jeyanathan M; Zganiacz A; Mandur T; Hammill J; Damjanovic D; Xing Z
J Immunol; 2015 Sep; 195(6):2900-7. PubMed ID: 26268652
[TBL] [Abstract][Full Text] [Related]
3. Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4
Das S; Marin ND; Esaulova E; Ahmed M; Swain A; Rosa BA; Mitreva M; Rangel-Moreno J; Netea MG; Barreiro LB; Divangahi M; Artyomov MN; Kaushal D; Khader SA
mBio; 2021 Aug; 12(4):e0146821. PubMed ID: 34253059
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccine.
Derrick SC; Evering TH; Sambandamurthy VK; Jalapathy KV; Hsu T; Chen B; Chen M; Russell RG; Junqueira-Kipnis AP; Orme IM; Porcelli SA; Jacobs WR; Morris SL
Immunology; 2007 Feb; 120(2):192-206. PubMed ID: 17076705
[TBL] [Abstract][Full Text] [Related]
5. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.
West NP; Thomson SA; Triccas JA; Medveczky CJ; Ramshaw IA; Britton WJ
Vaccine; 2011 Oct; 29(44):7759-65. PubMed ID: 21846485
[TBL] [Abstract][Full Text] [Related]
6. Induction of protective immunity against Mycobacterium tuberculosis by delivery of ESX antigens into airway dendritic cells.
Dong H; Stanek O; Salvador FR; Länger U; Morillon E; Ung C; Sebo P; Leclerc C; Majlessi L
Mucosal Immunol; 2013 May; 6(3):522-34. PubMed ID: 23032790
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.
Derrick SC; Yabe IM; Yang A; Morris SL
Vaccine; 2011 Apr; 29(16):2902-9. PubMed ID: 21338678
[TBL] [Abstract][Full Text] [Related]
8. Failure to recruit anti-inflammatory CD103+ dendritic cells and a diminished CD4+ Foxp3+ regulatory T cell pool in mice that display excessive lung inflammation and increased susceptibility to Mycobacterium tuberculosis.
Leepiyasakulchai C; Ignatowicz L; Pawlowski A; Källenius G; Sköld M
Infect Immun; 2012 Mar; 80(3):1128-39. PubMed ID: 22215739
[TBL] [Abstract][Full Text] [Related]
9. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
Wozniak TM; Ryan AA; Triccas JA; Britton WJ
Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
[TBL] [Abstract][Full Text] [Related]
10. CD11b
Lai R; Jeyanathan M; Afkhami S; Zganiacz A; Hammill JA; Yao Y; Kaushic C; Xing Z
J Immunol; 2018 Mar; 200(5):1746-1760. PubMed ID: 29374077
[No Abstract] [Full Text] [Related]
11. Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice.
Choi HG; Choi S; Back YW; Paik S; Park HS; Kim WS; Kim H; Cha SB; Choi CH; Shin SJ; Kim HJ
Oncotarget; 2017 Mar; 8(12):19947-19967. PubMed ID: 28193909
[TBL] [Abstract][Full Text] [Related]
12. Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines.
Mascart F; Locht C
Expert Rev Vaccines; 2015; 14(12):1573-85. PubMed ID: 26517361
[TBL] [Abstract][Full Text] [Related]
13. ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.
Kupz A; Zedler U; Stäber M; Perdomo C; Dorhoi A; Brosch R; Kaufmann SH
J Clin Invest; 2016 Jun; 126(6):2109-22. PubMed ID: 27111234
[TBL] [Abstract][Full Text] [Related]
14. Rationalized design of a mucosal vaccine protects against
Ahmed M; Jiao H; Domingo-Gonzalez R; Das S; Griffiths KL; Rangel-Moreno J; Nagarajan UM; Khader SA
J Leukoc Biol; 2017 Jun; 101(6):1373-1381. PubMed ID: 28258153
[TBL] [Abstract][Full Text] [Related]
15. Induction of high levels of protective immunity in mice after vaccination using dendritic cells infected with auxotrophic mutants of Mycobacterium tuberculosis.
Roy E; De Silva AD; Sambandamurthy VK; Clark SO; Stavropoulos E; Jacobs WR; Brennan J; Chan J; Williams A; Colston MJ; Tascon RE
Immunol Lett; 2006 Mar; 103(2):196-9. PubMed ID: 16297449
[TBL] [Abstract][Full Text] [Related]
16. Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.
Stylianou E; Pepponi I; van Dolleweerd CJ; Paul MJ; Ma JK; Reljic R
Vaccine; 2011 Mar; 29(12):2279-86. PubMed ID: 21272603
[TBL] [Abstract][Full Text] [Related]
17. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary mucosal dendritic cells in T-cell activation: implications for TB therapy.
McCormick S; Shaler CR; Xing Z
Expert Rev Respir Med; 2011 Feb; 5(1):75-85. PubMed ID: 21348588
[TBL] [Abstract][Full Text] [Related]
19. TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines.
Tyne AS; Chan JG; Shanahan ER; Atmosukarto I; Chan HK; Britton WJ; West NP
Vaccine; 2013 Sep; 31(40):4322-9. PubMed ID: 23880366
[TBL] [Abstract][Full Text] [Related]
20. Role and contribution of pulmonary CD103
Koh VH; Ng SL; Ang ML; Lin W; Ruedl C; Alonso S
Tuberculosis (Edinb); 2017 Jan; 102():34-46. PubMed ID: 28061951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
